11-Nov-2024 7:00 AM CST - Business Wire Establishment Labs Announces Participation in Upcoming Investment Conferences Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving womens health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in three upcoming investment conferences. Juan Jos Chacn-Quirs, Chief Executive Officer and Founder, and Raj Denhoy, Chief Financial Officer, will participate in the 2024 UBS Global Healthcare Conference being held November 11-14, 2024. Mr. Chac
7-Nov-2024 3:00 PM CST - Business Wire Establishment Labs Reports Third Quarter 2024 Financial Results Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving womens health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the third quarter ended September 30, 2024. Third Quarter Highlights and Outlook Third quarter worldwide revenue of $40.2 million. 2024 revenue guidance updated to $165 million to $168 million from previous guidance of $174 million to $184 mill
24-Oct-2024 7:00 AM CST - Business Wire Establishment Labs to Announce Third Quarter 2024 Financial Results on November 7 Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving womens health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended September 30, 2024, after the market closes on Thursday, November 7, 2024, and will host a conference call at 4:30 pm ET that day to discuss those results. To participate in the conference call, dial (877) 407-8037 (U.S.
11-Nov-2024 7:00 AM CST - Business Wire Establishment Labs Announces Participation in Upcoming Investment Conferences Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving womens health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in three upcoming investment conferences. Juan Jos Chacn-Quirs, Chief Executive Officer and Founder, and Raj Denhoy, Chief Financial Officer, will participate in the 2024 UBS Global Healthcare Conference being held November 11-14, 2024. Mr. Chac
7-Nov-2024 3:00 PM CST - Business Wire Establishment Labs Reports Third Quarter 2024 Financial Results Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving womens health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the third quarter ended September 30, 2024. Third Quarter Highlights and Outlook Third quarter worldwide revenue of $40.2 million. 2024 revenue guidance updated to $165 million to $168 million from previous guidance of $174 million to $184 mill
24-Oct-2024 7:00 AM CST - Business Wire Establishment Labs to Announce Third Quarter 2024 Financial Results on November 7 Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving womens health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended September 30, 2024, after the market closes on Thursday, November 7, 2024, and will host a conference call at 4:30 pm ET that day to discuss those results. To participate in the conference call, dial (877) 407-8037 (U.S.
